Sleep Disorders Trial, Recruiting NCT06720545 Sponsor: Columbia University Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06720545
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who speak English and whose sleep apnea treatment with a hypoglossal nerve stimulator (HGNS) — a device implanted to treat sleep apnea — has been working well, meaning it has reduced their breathing interruptions during sleep by at least 50% to below a certain threshold
  • People who have been using their HGNS device for at least 3 months and have used it for more than 20 hours per week over the past 4 weeks
  • People who were not using any other sleep apnea treatment for at least one month before their HGNS device was switched on, or who had at least one month of untreated sleep apnea after the device was activated

Who may not be able to join:

  • People who regularly use opioid (strong painkiller) medications, illicit drugs, or who have an alcohol dependency
  • Women who are pregnant or planning to become pregnant
  • People who work shift work, operate heavy machinery, or drive commercially as part of their job
  • People who have a history of very severe daytime sleepiness (based on a specific questionnaire score), or who have been in a car accident or near-miss incident caused by drowsy driving in the year before joining the trial
  • People with serious heart or lung conditions (such as needing home oxygen), serious liver, kidney, or cancer-related illness, a degenerative neurological condition, or an active or recent history of an eating disorder within the last 5 years
  • People who are not able to give their own informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 646-317-3252

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 January 2025
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Free living energy expenditure; Hypoxic burden

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov